This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Identify essential features to compare in no annual fee travel credit cards to maximize your benefits and savings.
17,165 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Paramount’s theater commitments could reshape local economies nationwide by expanding film production and theater act...
A retiree keeping 90% of a $1.7M portfolio in cash faces about $39,000 a year in lost growth, underscoring the long-t...
Retirees may secure a steadier paycheck by starting small and letting dividend growth drive long‑term income.
The 2026 maximum social security check is $5,181 per month. Here’s how large a private portfolio would need to be to ...
Investors are eyeing a renewed push for a classic dividend king as a robust oncology portfolio and resilience in earn...
A new staking-focused crypto ETF begins trading, promising 7% yield through Ethereum staking and easy access via a st...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
Institutional moves shape the AI stock landscape. This article dives into Philippe Laffont’s Coatue strategy, why Nvi...
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
Red Cat stock faced a sharp move that sparked questions about its future. This article breaks down what can cause a s...